Hashimoto Y - Search Results

1

Acute focal bacterial nephritis in an infant referred with apnea caused by mixed infection with Enterococcus raffinosus and Escherichia coli.

Kamioka Y, Izumida K, Ohtaka E, Hashimoto Y, Okada H, Narazaki H, Itoh Y. Kamioka Y, et al. Among authors: hashimoto y. J Nippon Med Sch. 2024 Aug 21. doi: 10.1272/jnms.JNMS.2025_92-502. Online ahead of print. J Nippon Med Sch. 2024. PMID: 39168615 Free article.

2

Interleukin-1beta Inhibition Attenuates Vasculitis in a Mouse Model of Kawasaki Disease.

Hashimoto Y, Fukazawa R, Nagi-Miura N, Ohno N, Suzuki N, Katsube Y, Kamisago M, Akao M, Watanabe M, Hashimoto K, Tsuno K, Matsui R, Itoh Y. Hashimoto Y, et al. Among authors: hashimoto k. J Nippon Med Sch. 2019;86(2):108-116. doi: 10.1272/jnms.JNMS.2019_86-206. J Nippon Med Sch. 2019. PMID: 31130561 Free article.

3

Virtual histology intravascular ultrasound evaluation of coronary artery lesions within 1 year and more than 10 years after the onset of Kawasaki disease.

Watanabe M, Fukazawa R, Ogawa S, Ohkubo T, Abe M, Hashimoto K, Hashimoto Y, Itoh Y. Watanabe M, et al. Among authors: hashimoto y, hashimoto k. J Cardiol. 2020 Feb;75(2):171-176. doi: 10.1016/j.jjcc.2019.06.015. Epub 2019 Aug 21. J Cardiol. 2020. PMID: 31444141 Free article.

4

Candesartan Attenuates Vasculitis in a Mouse Model of Kawasaki Disease Induced by Candida albicans Water-Soluble Fraction.

Matsui R, Fukazawa R, Fukunaga R, Motoji Y, Hashimoto Y, Watanabe M, Nagi-Miura N, Itoh Y. Matsui R, et al. Among authors: hashimoto y. J Nippon Med Sch. 2024;91(3):285-295. doi: 10.1272/jnms.JNMS.2024_91-307. J Nippon Med Sch. 2024. PMID: 38972741 Free article.

5

Hemodynamic Evaluation of Coronary Artery Lesions after Kawasaki Disease: Comparison of Fractional Flow Reserve during Cardiac Catheterization with Myocardial Flow Reserve during ¹³N-Ammonia PET.

Watanabe M, Fukazawa R, Kiriyama T, Imai S, Matsui R, Shimada K, Hashimoto Y, Hashimoto K, Abe M, Kamisago M, Itoh Y. Watanabe M, et al. Among authors: hashimoto y, hashimoto k. J Cardiovasc Dev Dis. 2024 Jul 23;11(8):229. doi: 10.3390/jcdd11080229. J Cardiovasc Dev Dis. 2024. PMID: 39195137 Free PMC article.

6

Three cases of young children who underwent effective catheter treatment for severe coronary stenosis caused by Kawasaki disease.

Watanabe M, Fukazawa R, Matsui R, Shimada K, Hashimoto Y, Hashimoto K, Abe M, Kamisago M. Watanabe M, et al. Among authors: hashimoto y, hashimoto k. J Cardiol Cases. 2023 Jan 17;27(4):180-183. doi: 10.1016/j.jccase.2023.01.001. eCollection 2023 Apr. J Cardiol Cases. 2023. PMID: 37012926 Free PMC article.

7

Statin suppresses the development of excessive intimal proliferation in a Kawasaki disease mouse model.

Motoji Y, Fukazawa R, Matsui R, Watanabe M, Hashimoto Y, Nagi-Miura N, Kitamura T, Miyaji K. Motoji Y, et al. Among authors: hashimoto y. Physiol Rep. 2024 Oct;12(20):e70096. doi: 10.14814/phy2.70096. Physiol Rep. 2024. PMID: 39424429 Free PMC article.

8

Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model.

Motoji Y, Fukazawa R, Matsui R, Abe Y, Uehara I, Watanabe M, Hashimoto Y, Miyagi Y, Nagi-Miura N, Tanaka N, Ishii Y. Motoji Y, et al. Among authors: hashimoto y. Int J Mol Sci. 2022 Dec 17;23(24):16108. doi: 10.3390/ijms232416108. Int J Mol Sci. 2022. PMID: 36555746 Free PMC article.

9

Influence of Worsening Renal Function and Baseline Chronic Kidney Disease on Clinical Outcomes in Patients With Chronic Coronary Syndromes: Insights From the REAL-CAD Study.

Yoshiki Y, Ozaki Y, Abe M, Ismail TF, Takahashi H, Akao M, Kawai H, Muramatsu T, Harada M, Ohta M, Hashimoto Y, Shiki Y, Koshikawa M, Miyajima K, Takatsu H, Niwa Y, Kawashima N, Ozaki R, Tsuboi N, Iimuro S, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Ogawa H, Daida H, Shimokawa H, Izawa H, Kimura T, Nagai R; REAL‐CAD investigators. Yoshiki Y, et al. Among authors: hashimoto y. J Am Heart Assoc. 2025 Jan 17:e034627. doi: 10.1161/JAHA.124.034627. Online ahead of print. J Am Heart Assoc. 2025. PMID: 39818975

10

Estimated Glucose Disposal Rate predicts the risk of incident Metabolic dysfunction-associated steatotic liver disease.

Ichikawa T, Hashimoto Y, Okamura T, Obora A, Kojima T, Okada H, Hamaguchi M, Fukui M. Ichikawa T, et al. Among authors: hashimoto y. Endocr Pract. 2025 Jan 14:S1530-891X(25)00020-5. doi: 10.1016/j.eprac.2025.01.002. Online ahead of print. Endocr Pract. 2025. PMID: 39818319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,354 results

Search Page

Filters